GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.06.18	Biotech Stocks Facing FDA Decision In July (RTTNews)
29.06.18	Novartis To Spin Off Alcon, Buy Back Up To $5 Bln Of Shares (RTTNews)
14.06.18	ViiV Healthcare: GEMINI 1&2 Studies Meets Primary Endpoint - Quick Facts (RTTNews)
12.06.18	GlaxoSmithKline Names Roger Connor President, Vaccines - Quick Facts (RTTNews)
01.06.18	Novartis Completes Divestment Of Stake In Consumer Healthcare JV - Quick Facts (RTTNews)
29.05.18	GSK Submits Application In Japan For Single Inhaler Triple Therapy FF/UMEC/VI (RTTNews)
21.05.18	GlaxoSmithKline Reports EU Marketing Authorisation For Juluca To Treat HIV (RTTNews)
09.05.18	GSK CFO Simon Dingemans To Retire (RTTNews)
01.05.18	Aqua Security and LogicHub Tie as Winners of Security Current's Security Shark Tank® During RSA 2018 (PR Newswire)
25.04.18	GSK Q1 Pre-tax Profit Down; Backs 2018 Adj. EPS View (RTTNews)
19.04.18	GlaxoSmithKline: IMPACT Study Shows Benefits Of Trelegy Ellipta In COPD Patients (RTTNews)
18.04.18	GlaxoSmithKline, Innoviva Says IMPACT Study Shows Benefits Of Trelegy Ellipta (RTTNews)
12.04.18	GSK To Transfer Rare Disease Gene Therapies To Orchard; Takes 19.9% Equity Stake (RTTNews)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
29.03.18	Teva Wins Reversal Of $235 Mln Glaxo's Coreg Drug Verdict (RTTNews)
27.03.18	GSK To Buyout Novartis' Stake In Consumer Healthcare JV For $13 Bln; Stock Up (RTTNews)
27.03.18	GSK To Acquire Novartis' Stake In Consumer Healthcare JV For $13.0 Bln (RTTNews)
23.03.18	ViiV Healthcare: CHMP Issues Positive Opinion For Juluca - Quick Facts (RTTNews)
23.03.18	GSK Withdraws From Process For Pfizer's Consumer Healthcare Unit; Stock Up (RTTNews)
23.03.18	GlaxoSmithKline: Europe, Japan Approve Shingrix To Prevent Shingles In Adults (RTTNews)
08.03.18	Innoviva, GSK: EU Approves Label Update To Relvar Ellipta In Asthma Patients (RTTNews)
05.03.18	ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis (PR Newswire)
14.02.18	GSK Submits IMPACT Data To EU To Support Trelegy Ellipta's Expanded Labelling (RTTNews)
08.02.18	ViiV Files Patent Infringement Lawsuit Against Gilead Sciences On Bictegravir (RTTNews)
07.02.18	GSK Posts Q4 Loss; Expects To Make Continued Progress In 2018 (RTTNews)
05.02.18	Bloomberg: Glaxo, Reckitt Submit Bids For Pfizer's Consumer Business Unit (RTTNews)
26.01.18	GSK's Shingrix Gets Positive CHMP Opinion For Prevention Of Shingles (RTTNews)
26.01.18	GlaxoSmithKline Gets Positive CHMP Opinion For Label Update Of Relvar Ellipta (RTTNews)
22.01.18	Some Branded Drugs Going Generic In 2018 (RTTNews)
12.01.18	GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older (PR Newswire)
27.12.17	Biotech Stocks Facing FDA Decision In January 2018 (RTTNews)
22.12.17	Significant increase of Group Net Income as a result of the tax reform in the U.S. (PR Newswire)
21.12.17	GlaxoSmithKline Says FDA Oks US Label Update On ICS/LABA Combinations In Asthma (RTTNews)
13.12.17	ADRO Dumps CRS-207, Another Win For CoolSculpting, FDA Expands GSK's Nucala Use (RTTNews)
13.12.17	GSK Gets FDA Approval For Nucala For Treatment Of EGPA For Adults (RTTNews)
12.12.17	GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US (PR Newswire)
12.12.17	GSK Presents Promising New Data From GSK2857916 Study In Multiple Myeloma (RTTNews)
08.12.17	New Drugs Approved In November (RTTNews)
06.12.17	GSK: Phase III Data Supports Efficacy Of Shingrix In Preventing Shingles (RTTNews)
23.11.17	GlaxoSmithKline, Innoviva File For Supplementary NDA For Trelegy Ellipta (RTTNews)
22.11.17	First 2-drug HIV Regimen Gets FDA Nod, Starpharma Shines, ARDX Drops RDX7675 (RTTNews)
22.11.17	ViiV Healthcare : FDA Okays First Two-drug Regimen For Certain Patients With HIV (RTTNews)
22.11.17	Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection (PR Newswire)
20.11.17	TESARO, Inc. Co-Founders named Entrepreneur Of The Year® 2017 National Overall Award winners (PR Newswire)
17.11.17	FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche (RTTNews)
07.11.17	New Drugs Approved In October (RTTNews)
26.10.17	It's A No For PTCT As Expected, SRPT Revises Outlook Higher, TSRO Gets FDA Nod (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft